About Kinentia Biosciences
Kinentia Biosciences is a company based in Albany (United States) founded in 2007 by David Fairfax. It operates as a B2B. Kinentia Biosciences offers products and services including Deep Data Mining, Contract Research, Consulting Services, and Chemical Catalog. Kinentia Biosciences operates in a competitive market with competitors including Insitro, HotSpot Therapeutics, Certara, Inpharmatica and TOLREMO therapeutics, among others.
- Headquarter Albany, United States
- Founders David Fairfax
-
Sectors
Technology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kinentia Biosciences, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kinentia Biosciences
Kinentia Biosciences offers a comprehensive portfolio of products and services, including Deep Data Mining, Contract Research, Consulting Services, and Chemical Catalog.
Technology for risk mitigation in pharmaceutical drug discovery
Support for drug discovery and development activities
Expertise in CRO management and materials procurement
Collection of chemical intermediates and natural products
Funding Insights of Kinentia Biosciences
Investments & Acquisitions by Kinentia Biosciences
Financial Statements - Kinentia Biosciences
Kinentia Biosciences Comparisons
Competitors of Kinentia Biosciences
Kinentia Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, HotSpot Therapeutics, Certara, Inpharmatica and TOLREMO therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for protein function analysis
|
|
| domain | founded_year | HQ Location |
Provider of a platform for in silico drug discovery and consulting services
|
|
| domain | founded_year | HQ Location |
Developer of predictive informatics based platform for drug discovery
|
|
| domain | founded_year | HQ Location |
Anti-cancer small molecules are developed to target drug resistance pathways.
|
|
| domain | founded_year | HQ Location |
Immune system-based drugs are discovered via biological data analytics.
|
Latest news on Kinentia Biosciences
Frequently Asked Questions about Kinentia Biosciences
Kinentia Biosciences was founded in 2007.
Kinentia Biosciences is headquartered in Albany, United States.
David Fairfax is the current CEO of Kinentia Biosciences. They have also founded this company.
Kinentia Biosciences, founded in 2007, utilizes Deep Data Mining technology to support clients in discovering and developing novel pharmaceutical agents by mitigating risks in the process. They offer contract research, manufacturing, and consulting services, including ADMET screening and global CRO management. Operating GLP and c-GMP facilities in the USA, the company is based in Rensselaer, New York, and serves pharmaceutical clients through in-house discovery to commercialization activities.
Kinentia Biosciences's top competitors include Insitro, HotSpot Therapeutics and Certara.
Kinentia Biosciences offers Deep Data Mining, Contract Research, Consulting Services, and Chemical Catalog.